Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Apoptosis01:30

Apoptosis

11.8K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

6.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

1.6K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esketamine improves postoperative sleep quality in thoracic surgery patients with preoperative sleep disturbance: a randomized controlled trial.

Frontiers in pharmacology·2026
Same author

Establishment and preliminary application of an ELISA method for detecting antibodies to field strains of bovine infectious rhinotracheitis virus.

Veterinary journal (London, England : 1997)·2026
Same author

Non-small cell lung cancer after EGFR-TKI resistance: from drug resistance mechanisms to precision interventions.

Frontiers in pharmacology·2026
Same author

Immune cells mediate the association between type 1 diabetes and immune thrombocytopenia: an observational and Mendelian randomization study.

Journal of diabetes and metabolic disorders·2026
Same author

m6A RNA modifications in neurosystem genes as early markers for osteoporosis with iron accumulation.

Molecular biology reports·2026
Same author

Changes in functional connectivity of the default mode network and thalamus may be a therapeutic mechanism for the treatment of major depressive disorder with vortioxetine.

Psychiatry research. Neuroimaging·2026

Related Experiment Video

Updated: Aug 28, 2025

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.9K

Dioscin Regulating Bone Marrow Apoptosis in Aplastic Anemia.

Le Zhang1, Runfeng Ni1, Jiani Li2

  • 1Department of Traditional Chinese Medicine, General Hospital of Tianjin Medical University, Tianjin, 300052, People's Republic of China.

Drug Design, Development and Therapy
|September 15, 2022
PubMed
Summary

Dioscin (DNS) effectively treats aplastic anemia (AA) by restoring blood cell counts and bone marrow function in mice. It inhibits CD8+ T-cell-mediated apoptosis via the Fas signaling pathway, offering a potential alternative to traditional therapies.

Keywords:
Fas/FasLaplastic anemiaapoptosisdioscinmice

More Related Videos

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.3K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K

Related Experiment Videos

Last Updated: Aug 28, 2025

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.9K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.3K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K

Area of Science:

  • Hematology
  • Immunology
  • Pharmacology

Background:

  • Aplastic anemia (AA) is a bone marrow failure disease driven by CD8+ T-cell-induced apoptosis of hematopoietic cells.
  • Current immunosuppressive therapies (IST) for AA have significant toxicities and variable efficacy.

Purpose of the Study:

  • To investigate the therapeutic effects and underlying mechanisms of dioscin (DNS) in treating aplastic anemia.

Main Methods:

  • An AA mouse model was established and treated with DNS or control drugs for 14 days.
  • Evaluated bone marrow pathology, apoptosis rates of bone marrow mononuclear cells (BMMCs), and Fas (CD95) expression on CD34+ cells.
  • Assessed key proteins within the Fas signaling pathway.

Main Results:

  • DNS treatment significantly increased peripheral blood cell counts (granulocytes, erythrocytes, hemoglobin, platelets, reticulocytes) in AA mice.
  • DNS reduced BMMC apoptosis rates and decreased CD95 expression on CD34+ cells.
  • Key proteins in the Fas signaling pathway were significantly downregulated following DNS intervention.

Conclusions:

  • DNS effectively reverses pancytopenia and bone marrow failure in a mouse model of AA.
  • DNS exerts its therapeutic effect by inhibiting the Fas signaling pathway, thereby reducing bone marrow cell apoptosis.